Kenneth A. Solen
Directeur Technique/Scientifique/R&D chez Utah Artificial Heart Institute
Profil
Kenneth A.
Solen is the founder of ThromboVision, Inc. founded in 2005, where he held the title of Director in 2009.
He is currently the Engineering Director at Utah Artificial Heart Institute and a Professor at Brigham Young University.
Dr. Solen received his doctorate degree from the University of Wisconsin in 1974 and his undergraduate degree from the same university in 1972.
Postes actifs de Kenneth A. Solen
Sociétés | Poste | Début |
---|---|---|
Utah Artificial Heart Institute | Directeur Technique/Scientifique/R&D | - |
Brigham Young University | Corporate Officer/Principal | - |
Anciens postes connus de Kenneth A. Solen
Sociétés | Poste | Fin |
---|---|---|
ThromboVision, Inc.
ThromboVision, Inc. Medical SpecialtiesHealth Technology ThromboVision, Inc. develops diagnostics products. It is a biomedical company which enables people to lead longer and healthier lives. The firm provides easy-to-use, rapid-response and versatile clinical diagnostic discoveries that advance medical diagnosis. The company was founded by Kenneth A. Solen, Edward R. Teitel and Sivaprasad Sukavaneshvar in 2005 and is headquartered in Houston, TX. | Fondateur | - |
Formation de Kenneth A. Solen
University of Wisconsin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
ThromboVision, Inc.
ThromboVision, Inc. Medical SpecialtiesHealth Technology ThromboVision, Inc. develops diagnostics products. It is a biomedical company which enables people to lead longer and healthier lives. The firm provides easy-to-use, rapid-response and versatile clinical diagnostic discoveries that advance medical diagnosis. The company was founded by Kenneth A. Solen, Edward R. Teitel and Sivaprasad Sukavaneshvar in 2005 and is headquartered in Houston, TX. | Health Technology |
Utah Artificial Heart Institute |